Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2026		Dec. 31, 2025
Securities available for sale, amortized cost	$ 2,857,903	[1]	$ 2,646,414	[2]
Securities held to maturity, fair value	$ 2,227,000	[3]	$ 2,246,526	[4]
Common stock, par value (usd per share)	$ 0.01		$ 0.01
Common stock, outstanding (in shares)	153,722,123		149,963,520
Common stock, issued (in shares)	153,784,724		150,039,018
Allowance for Credit Loss	$ (775)		$ (775)
Class B Nonvoting
Common stock, par value (usd per share)	$ 0.01		$ 0.01
Common stock, outstanding (in shares)	477,321
Common stock, issued (in shares)	477,321		477,321
Nonvoting Common Stock
Common stock, par value (usd per share)	$ 0.01		$ 0.01
Common stock, issued (in shares)	0		5,017,064
Credit-linked notes
Credit-linked Notes	$ 111,250		$ 113,634

[1] Excludes accrued interest receivable of $12.3 million at March 31, 2026 which is recorded in "Other assets" on the consolidated balance sheets.

[2] Excludes accrued interest receivable of $11.4 million at December 31, 2025 which is recorded in "Other assets" on the consolidated balance sheets.

[3] Excludes accrued interest receivable of $11.2 million at March 31, 2026 which is recorded in "Other assets" on the consolidated balance sheet

[4] Excludes accrued interest receivable of $13.4 million at December 31, 2025 which is recorded in "Other assets" on the consolidated balance sheets